Day One Bio Day One Bio

Together, it’s time to rethink pLGG.

Learn more about pediatric low-grade glioma (pLGG), the most common brain tumor in children.

Supporting the Community

To ensure that we support the pediatric cancer community in the most meaningful and thoughtful way, we asked the community what matters most to them when engaging with a pharmaceutical company. What they shared is now reflected in our four Patient Advocacy Engagement Principles:

These Principles are based on mutual respect, transparent and authentic communications, and long-term partnerships and collaboration to take on the enormous challenges facing children with cancer and their families.

  • Christa Kerkorian

    Christa Kerkorian

    Vice President of Patient Advocacy

    Christa Kerkorian

    Christa Kerkorian

    Vice President of Patient Advocacy

    I lead the Patient Advocacy team at Day One. I partner with childhood cancer non-profit organizations, patients, and families to ensure that their experiences and insights are understood and considered by Day One teams, as we make decisions and develop new treatment options for children with cancer. The work we do impacts patients and families in that it helps Day One become better informed in how best to support the patients and families in everything we do—from clinical trials, to disease awareness/education, support services, public policy, and everything in between!
    Close
  • Kelli Wright

    Kelli Wright

    Director of Patient Advocacy

    Kelli Wright

    Kelli Wright

    Director of Patient Advocacy

    As part of the Patient Advocacy team at Day One, working with the pediatric brain tumor community, I have the honor of connecting with patients, families and community leaders to learn what life is like with a brain tumor. This could include the diagnosis and treatment journey, the impact of side effects and survivorship/long-term effects, or life during or after treatment. That information is then shared with teams at Day One to ensure that the patient voice is heard as the company makes drug development and business decisions. For almost 11 years, I worked at CureSearch for Children’s Cancer, a national non-profit organization working to accelerate cures for children with cancer. While working with pharmaceutical leaders at CureSearch, I recognized the impact patients and families can have to improve the drug development process. Patient Advocacy is the connecter between patients and families and the teams within Day One. What we do every day will ultimately and directly impact the disease communities we serve.
    Close

You are now leaving the Day One Biopharmaceuticals Corporate Website

You will now be redirected to the requested website. Please confirm that you want to proceed.